NO20024363D0 - New LHRH antagonists, their production and use as a drug - Google Patents

New LHRH antagonists, their production and use as a drug

Info

Publication number
NO20024363D0
NO20024363D0 NO20024363A NO20024363A NO20024363D0 NO 20024363 D0 NO20024363 D0 NO 20024363D0 NO 20024363 A NO20024363 A NO 20024363A NO 20024363 A NO20024363 A NO 20024363A NO 20024363 D0 NO20024363 D0 NO 20024363D0
Authority
NO
Norway
Prior art keywords
drug
production
lhrh antagonists
hormone
peptides
Prior art date
Application number
NO20024363A
Other languages
Norwegian (no)
Other versions
NO20024363L (en
Inventor
Michael Bernd
Bernhard Kutscher
Eckhard Guenther
Peter Romeis
Thomas Reissmann
Thomas Beckers
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/525,007 external-priority patent/US6627609B1/en
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of NO20024363D0 publication Critical patent/NO20024363D0/en
Publication of NO20024363L publication Critical patent/NO20024363L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to peptides, comprising an N-methylated amino acid component and an improved water solubility. According to the invention, medicaments containing the said peptides can be used for treatment of hormone-dependant tumours and hormone-influenced non-malignant disease states.
NO20024363A 2000-03-14 2002-09-12 New LHRH antagonists, their production and use as a drug NO20024363L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/525,007 US6627609B1 (en) 1999-03-17 2000-03-14 LHRH antagonists having improved solubility properties
PCT/EP2001/002719 WO2001068676A2 (en) 2000-03-14 2001-03-12 Lhrh-antagonists, production and use thereof as medicament

Publications (2)

Publication Number Publication Date
NO20024363D0 true NO20024363D0 (en) 2002-09-12
NO20024363L NO20024363L (en) 2002-11-13

Family

ID=24091545

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024363A NO20024363L (en) 2000-03-14 2002-09-12 New LHRH antagonists, their production and use as a drug

Country Status (25)

Country Link
EP (1) EP1268522B1 (en)
JP (1) JP3805679B2 (en)
KR (1) KR100607396B1 (en)
CN (2) CN1443195A (en)
AT (1) ATE408619T1 (en)
AU (2) AU6011001A (en)
BG (1) BG107121A (en)
BR (1) BR0109279A (en)
CA (1) CA2402193C (en)
DE (1) DE50114335D1 (en)
DK (1) DK1268522T3 (en)
ES (1) ES2312435T3 (en)
HR (1) HRP20020810A2 (en)
HU (1) HUP0300222A3 (en)
IL (1) IL151647A0 (en)
MX (1) MXPA02008870A (en)
NO (1) NO20024363L (en)
NZ (1) NZ521273A (en)
PL (1) PL357999A1 (en)
PT (1) PT1268522E (en)
RU (1) RU2248982C9 (en)
SK (1) SK14332002A3 (en)
UA (1) UA79070C2 (en)
WO (1) WO2001068676A2 (en)
ZA (1) ZA200207248B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100340572C (en) * 2004-12-01 2007-10-03 中国人民解放军军事医学科学院毒物药物研究所 Novel LHRH antagonist
CN101037472B (en) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 LHRH antagonist with low-histamine releasing function
DK2252627T3 (en) 2008-01-24 2017-08-14 Esperance Pharmaceuticals MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME.
CN101597321B (en) * 2008-06-03 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 LHRH antagonist with long-acting low-histamine release side effect
WO2010142060A1 (en) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 Lhrh antagonist with long potency and low histamine releasing effect
WO2014070957A1 (en) 2012-10-30 2014-05-08 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
CN104418936B (en) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh antagonist derivative and its medicinal usage
FR3024612B1 (en) * 2014-08-04 2018-03-09 Alstom Transp Tech POWER SUPPLY MODULE OF A MOTOR BLOCK, TRACTION SYSTEM AND ELECTRIC VEHICLE
RU2585367C1 (en) * 2014-11-05 2016-05-27 Наталья Владимировна Спиридонова Method of treating infertility in females suffering from uterine myoma

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140009A (en) 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5110904A (en) 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
IL101074A (en) 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
ES2052488T3 (en) 1991-04-25 1997-01-01 Romano Deghenghi ANTAGONIST PEPTIDES OF THE LUTEINIZING HORMONE RELEASE HORMONE.
CA2136078A1 (en) 1992-12-04 1994-06-23 Jonathan Greer 6-position modified decapeptide lhrh antagonists
ES2164096T3 (en) 1992-12-18 2002-02-16 Abbott Lab LHRH ANTAGONISTS UNDERSTANDING AMINOACIT REMAINS MODIFIED IN POSITION 5 AND 6.
IL108509A0 (en) 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
DE4320201A1 (en) * 1993-06-18 1995-01-12 Asta Medica Ag Use of Cetrorelix and other nona and decapeptides for the manufacture of a medicament for combating AIDS and for growth stimulation
DE19544212A1 (en) 1995-11-28 1997-06-05 Asta Medica Ag New LH-RH antagonists with improved effects
DE19911771B4 (en) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH antagonist, process for its preparation and its use

Also Published As

Publication number Publication date
AU2001260110B2 (en) 2005-05-05
KR20020083179A (en) 2002-11-01
ATE408619T1 (en) 2008-10-15
BR0109279A (en) 2002-12-17
DK1268522T3 (en) 2009-01-12
CN100500692C (en) 2009-06-17
UA79070C2 (en) 2007-05-25
MXPA02008870A (en) 2003-06-24
DE50114335D1 (en) 2008-10-30
HUP0300222A3 (en) 2004-08-30
EP1268522A2 (en) 2003-01-02
PT1268522E (en) 2008-12-22
CA2402193C (en) 2010-05-18
RU2248982C2 (en) 2005-03-27
ZA200207248B (en) 2003-02-21
ES2312435T3 (en) 2009-03-01
NO20024363L (en) 2002-11-13
SK14332002A3 (en) 2003-09-11
AU6011001A (en) 2001-09-24
NZ521273A (en) 2005-01-28
HUP0300222A2 (en) 2003-07-28
CN1443195A (en) 2003-09-17
JP2003535044A (en) 2003-11-25
JP3805679B2 (en) 2006-08-02
IL151647A0 (en) 2003-04-10
EP1268522B1 (en) 2008-09-17
KR100607396B1 (en) 2006-08-02
PL357999A1 (en) 2004-08-09
HRP20020810A2 (en) 2004-12-31
RU2248982C9 (en) 2005-06-10
WO2001068676A2 (en) 2001-09-20
BG107121A (en) 2003-05-30
CN1876677A (en) 2006-12-13
WO2001068676A3 (en) 2002-10-24
CA2402193A1 (en) 2002-09-09

Similar Documents

Publication Publication Date Title
DK1178958T3 (en) N-cyanomethylamides as protease inhibitors
CY1108085T1 (en) Substituted 1,3-bisphenylprop-2-en-1-one derivatives for the production and use thereof
HRP20041152B1 (en) Pharmaceutical formulations
DE60138468D1 (en) CYANOPHENOXY CARBOXYLIC ACIDS AND COMPOSITIONS FOR THE RELEASE OF ACTIVE SUBSTANCES
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
IS6491A (en) Pteridine compounds for the treatment of psoriasis
DE60134245D1 (en) (5- (2-HYDROXY-4-CHLOROBENZOYL) VALERIANIC ACID AND ITS SALTS, AND COMPOSITIONS FOR ADDING ACTIVITIES CONTAINING THESE COMPOUNDS
YU68702A (en) Novel lhrh-antagonists, production and use thereof as medicament
CY1105028T1 (en) SUBSTITUTED C-IMIDAZO-[1,2-A]PYRIDIN-3-YL-METHYLAMINES
HK1068606A1 (en) Novel aminobenzoephenones
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
NO20024363D0 (en) New LHRH antagonists, their production and use as a drug
CY1105019T1 (en) SUBSTITUTED C-IMIDAZO-[1,2-A]PYRIDIN-3-YL-METHYLAMINES
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
SE0102440D0 (en) New compound
DE50105771D1 (en) IBUPROFEN-ACTIVE PREPARATION
SE0100566D0 (en) Compounds
SE0001916D0 (en) Novel formulation
EA200501565A1 (en) INTENDED FOR ORAL ADMINISTRATION MEDICINE FORM FOR PROTONE PUMP ANTAGONISTS
SE0101692D0 (en) Compounds
DE60300683D1 (en) Prucalopride NOXIDE
DE50212538D1 (en) SUBSTITUTED 5,6,6A, 11B-TETRAHYDRO-7-OXA-5-AZA-BENZOACOFLUORES-6-CARBOXYLIC ACID DERIVATIVES AS NMDA ANTAGONISTS
DE50304524D1 (en) DRUGS INCLUDED SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLE
ITUD20030196A1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL DOSAGES CONTAINING MANY ACTIVE PRINCIPLES.
MXPA04000918A (en) Pramipexol as an anticonvulsive agent.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application